Éric Rouvier
- Immunology top 1%
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 2
- Dermatology top 2%
- Oncology top 5%
-
- Radiopharmaceutical Chemistry and Applications 16
- Monoclonal and Polyclonal Antibodies Research 14
-
- Lymphoma Diagnosis and Treatment 6
-
- Thyroid Cancer Diagnosis and Treatment 4
-
- Neuroendocrine Tumor Research Advances 3
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Pierre GolsteinM F LucianiMarie‐Geneviève MattéiFrançois DenizotFrançois FossiezSmina Aït‐YahiaPierre GarroneSerge Lebecque
- Cited by
- ImmunologyDermatologyOncology
- Journals
- International Journal of Cancer (3 papers)Cancer (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- FranceSwitzerlandArgentina
In The Last Decade
Éric Rouvier
26 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Immunology 2.2k
- Dermatology 241
- Oncology 740
- Radiology, Nuclear Medicine and Imaging 569
- Pathology and Forensic Medicine 402
Countries citing papers authored by Éric Rouvier
This map shows the geographic impact of Éric Rouvier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Rouvier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Rouvier more than expected).
Fields of papers citing papers by Éric Rouvier
This network shows the impact of papers produced by Éric Rouvier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Rouvier. The network helps show where Éric Rouvier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Éric Rouvier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 1 | |
| 2 | 2001 | 67 | |
| 3 | Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery. | 2000 | 18 |
| 4 | Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten. | 2000 | 63 |
| 5 | 1999 | 73 | |
| 6 | Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial. | 1999 | 42 |
| 7 | Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. | 1999 | 7 |
| 8 | Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens. | 1998 | 37 |
| 9 | 1997 | 8 | |
| 10 | 1997 | 5 | |
| 11 | 1997 | 3 | |
| 12 | 1997 | 26 | |
| 13 | 1997 | 7 | |
| 14 | T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.breakdown → | 1996 | 1240 |
| 15 | Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. | 1996 | 42 |
| 16 | 1996 | 13 | |
| 17 | 1995 | 8 | |
| 18 | 1994 | 24 | |
| 19 | Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.breakdown → | 1993 | 721 |
| 20 | 1991 | 358 |
About Éric Rouvier
Éric Rouvier is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism, having authored 26 papers that have together received 3.6k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Lymphoma Diagnosis and Treatment (6 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Neuroendocrine Tumor Research Advances (3 papers), T-cell and B-cell Immunology (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Immunology (2.2k citations), Dermatology (241 citations) and Oncology (740 citations). Éric Rouvier has collaborated with scholars based in France, Switzerland and Argentina. Frequent co-authors include Pierre Golstein, M F Luciani, Marie‐Geneviève Mattéi, François Denizot, François Fossiez, Smina Aït‐Yahia, Pierre Garrone, Serge Lebecque, Baishakhi Mahapatra and E Grau Garcia. Their work appears in journals such as International Journal of Cancer, Cancer, The Journal of Immunology, The Journal of Experimental Medicine and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.